Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous expanded adipose-derived stem cells for urinary incontinence after radical prostatectomy
2009-016298-14Phase 2Active
- Sponsor
- FIBHULP
- Start
- Feb 2010
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of expanded adipose-derived stem cells in urinary incontinence (UI), sponsored by FIBHULP. Primary endpoints: Feasibility and safety and Cumulative incidence of therapy-attributed adverse events. Started Feb 2010; status: active.
02
Drugs
expanded adipose-derived stem cells
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on 2009-016298-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016298-14.